Chapter 17 – Perivascular Peptides (NPY, CGRP, and SP) in Hypertension and Congestive Heart Failure

[1]  D. Erlinge,et al.  Sensory nerve terminal activity in severe hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P. , 1992, Blood pressure.

[2]  D. Erlinge,et al.  Neuropeptide Y-like immunoreactivity and hypertension , 1992, Journal of hypertension.

[3]  R. Ekman,et al.  Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors , 1991, Journal of internal medicine.

[4]  R. Ekman,et al.  Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man , 1991, Regulatory Peptides.

[5]  M. Zaidi,et al.  Enhanced circulating levels of neurally derived calcitonin gene related peptide in spontaneously hypertensive rats. , 1991, Cardiovascular research.

[6]  A. Sollevi,et al.  Elevation of plasma neuropeptide Y‐like immunoreactivity and noradrenaline during myocardial ischaemia in man , 1990, Journal of internal medicine.

[7]  B. Kennedy,et al.  Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. , 1990, American journal of hypertension.

[8]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[9]  A. Saito,et al.  Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat. , 1990, Circulation research.

[10]  P. Goadsby,et al.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache , 1990, Annals of neurology.

[11]  D. Abbott,et al.  Neuropeptide Y in rat sympathetic neurons is altered by genetic hypertension and by age. , 1990, Hypertension.

[12]  R. Ekman,et al.  Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills. , 1990, Scandinavian journal of clinical and laboratory investigation.

[13]  R. Ekman,et al.  Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres , 1990, European journal of clinical investigation.

[14]  A. Sollevi,et al.  Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. , 1990, Cardiovascular research.

[15]  R. Ekman,et al.  Calcitonin gene-related peptide-LI in subarachnoid haemorrhage in man. Signs of activation of the trigemino-cerebrovascular system? , 1990, British journal of neurosurgery.

[16]  L. Liu,et al.  Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension. , 1989, Chinese medical journal.

[17]  R. Ekman,et al.  Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man. , 1989, Journal of human hypertension.

[18]  E. Espiner,et al.  ATRIAL NATRIURETIC PEPTIDE LEVELS IN CONGESTIVE HEART FAILURE IN MAN BEFORE AND DURING CONVERTING ENZYME INHIBITION , 1989, Clinical and experimental pharmacology & physiology.

[19]  H. Motulsky,et al.  Elevation of plasma neuropeptide Y levels in congestive heart failure. , 1989, The American journal of medicine.

[20]  D. Ganten,et al.  Converting Enzyme Inhibitors and Their Effects on the Renin‐Angiotensin System of the Blood Vessel Wall , 1989, Journal of cardiovascular pharmacology.

[21]  T. Hökfelt,et al.  Increased neuropeptide Y messenger RNA and peptide in sympathetic ganglia after reserpine pretreatment. , 1988, European journal of pharmacology.

[22]  V. Dzau.  Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure. , 1988, The American journal of cardiology.

[23]  K. Goto,et al.  Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat , 1988, Nature.

[24]  T. Hedner,et al.  Atrial natriuretic peptide and catecholamines in peripheral blood as indicators of cardiac dysfunction in the general population. , 1988, Clinical science.

[25]  J. McEwan,et al.  Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. , 1988, Circulation.

[26]  E. Potter.  Neuropeptide Y as an autonomic neurotransmitter. , 1988, Pharmacology & therapeutics.

[27]  G. Francis,et al.  Neuroendocrine manifestations of congestive heart failure. , 1988, The American journal of cardiology.

[28]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[29]  C. Triggle,et al.  Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. , 1987, Hypertension.

[30]  A. Hughes,et al.  The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro. , 1987, British journal of clinical pharmacology.

[31]  P. Barnes,et al.  Effect of substance P on cardiovascular and respiratory function in subjects. , 1987, Journal of applied physiology.

[32]  P. Thorén,et al.  Efferent renal nerve traffic in the spontaneously hypertensive rat. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.

[33]  P. Hjemdahl,et al.  Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. , 2008, Clinical physiology.

[34]  J. Stevenson,et al.  Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. , 1986, British medical journal.

[35]  R. Mccarty.  Sympathetic nervous system development in hypertensive rats. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[36]  J. Polak,et al.  Capsaicin induces a depletion of calcitonin gene-related peptide (CGRP)-immunoreactive nerves in the cardiovascular system of the guinea pig and rat. , 1986, Journal of the autonomic nervous system.

[37]  K. Swedberg,et al.  Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. , 1986, European heart journal.

[38]  J. Mcculloch,et al.  Calcitonin gene-related peptide: functional role in cerebrovascular regulation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  F. Sundler,et al.  Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects , 1986, Regulatory Peptides.

[40]  G. Riegger,et al.  Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.

[41]  A. Mark,et al.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.

[42]  H. Morris,et al.  Human calcitonin gene related peptide: a potent endogenous vasodilator in man. , 1986, Clinical science.

[43]  G. Reeder,et al.  Atrial natriuretic peptide elevation in congestive heart failure in the human. , 1986, Science.

[44]  C. Bell,et al.  Catecholamines in Kidneys of Normotensive and Genetically Hypertensive Rats Effects of Salt Load , 1986, HYPERTENSION.

[45]  T. Hökfelt,et al.  Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications. , 1986, Progress in brain research.

[46]  C. Patlak,et al.  A Spatial Analysis of the Blood—Brain Barrier Damage in Experimental Allergic Encephalomyelitis , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  P. Hjemdahl,et al.  Co-release of neuropeptide Y and catecholamines during physical exercise in man. , 1985, Biochemical and biophysical research communications.

[48]  J. Mcculloch,et al.  Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P , 1985, Neuroscience Letters.

[49]  C. Wahlestedt,et al.  Innervation of human omental arteries and veins and vasomotor responses to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide , 1985, Regulatory Peptides.

[50]  M. Costa,et al.  Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs , 1985, Neuroscience Letters.

[51]  T. Hökfelt,et al.  Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. , 1985, European journal of pharmacology.

[52]  S. Bloom,et al.  Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. , 1984, The Journal of physiology.

[53]  J. Cohn,et al.  The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.

[54]  M. Packer,et al.  Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. , 1984, The New England journal of medicine.

[55]  D. Goldstein,et al.  Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. , 1983, Hypertension.

[56]  C. Su,et al.  Enhanced presynaptic beta adrenoceptor-mediated modulation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. , 1982, The Journal of pharmacology and experimental therapeutics.

[57]  S. Oparil,et al.  Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. , 1980, The Journal of clinical investigation.

[58]  D. K. Meyer,et al.  INFLUENCE OF CONVERTING ENZYME INHIBITION ON THE RELEASE OF VASOPRESSIN INDUCED BY ANGIOTENSIN , 1980, British journal of pharmacology.

[59]  R. Kline,et al.  Effect of renal denervation on the development of hypertension in spontaneously hypertensive rats. , 1978, Canadian journal of physiology and pharmacology.

[60]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[61]  W. Judy,et al.  Sympathetic Nerve Activity: Role in Regulation of Blood Pressure in the Spontaneously Hypertensive Rat , 1976, Circulation research.

[62]  B. Folkow,et al.  Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). , 1974, Acta physiologica Scandinavica.

[63]  D. Clark.  Effects of Immunosympathectomy on Development of High Blood Pressure in Genetically Hypertensive Rats , 1971, Circulation research.

[64]  B. Folkow,et al.  Structurally based increase of flow resistance in spontaneously hypertensive rats. , 1970, Acta physiologica Scandinavica.

[65]  K. Okamoto,et al.  Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rat. , 1967, Japanese heart journal.